According to Caixin News on November 17 (Editor: Li Chen), this year, guided and encouraged by policies, listed companies have further improved their regular dividend mechanisms, continuously enhancing their dividend awareness and increasing their dividend levels. With the disclosure of the third quarterly reports completed, several listed companies including chongqing sokon industry group stock, shantui construction machinery, chongqing fuling electric power industrial, jiangsu linyang energy, yiyi shares, and zibo qixiang tengda chemical have announced cash dividend plans for the third quarter or the first three quarters, according to incomplete statistics from Caixin News.

Statistics from the China Listed Companies Association show that the number of A-share listed companies on the Shanghai and Shenzhen stock exchanges that released cash dividend proposals with the third quarterly reports in 2024 and the total amount of dividends both reached historical highs, and the level of returns for investors from listed companies continues to improve.

Wind data indicates that in terms of the pre-tax cash dividend per share, six listed companies including g-bits network technology, shenzhen mindray bio-medical electronics, yunnan baiyao group, deye shares, china resources sanjiu medical & pharmaceutical, and Allianz Rui Shi plan to distribute cash dividends of more than 1 yuan per share (including tax). Among them, g-bits network technology ranks first on the third quarter dividend list with a payout of 2 yuan per share. Detailed information is as follows:

On November 15, g-bits network technology announced that it plans to distribute a cash dividend of 2.00 yuan (including tax) per share to all shareholders for the third quarter of 2024, with a record date of November 22, 2024, and an ex-dividend date of November 25, 2024. In a research report released by He Chen and others at Caixin Securities on October 31, it was stated that g-bits network technology values shareholder returns and enhances long-term investment value. g-bits network technology has increased the frequency of dividends, announcing a profit distribution plan for the third quarter of 2024, proposing to distribute cash dividends of 20.00 yuan (including tax) for every 10 shares, totaling 0.144 billion yuan in cash dividends, accounting for 102.86% of the corresponding net income attributable to shareholders. The cumulative cash dividends of g-bits network technology for the first three quarters of 2024 amounted to 0.466 billion yuan, accounting for 70.94% of the corresponding net income attributable to shareholders. The total cash dividends and cumulative repurchase amount for the first three quarters of 2024 was 0.519 billion yuan, accounting for 78.87% of the corresponding net income attributable to shareholders. Analysts suggest paying attention to the subsequent rhythm and performance of new product launches. "Wen Jian Chang Sheng (Code: M72)" and "Zhang Jian Chuan Shuo (Code: M88)" were subjected to the first paid testing from August to September 2024 and are scheduled to be launched in the first half of 2025. In addition, "Wang Du Chuang Shi Lu" and "Feng Shen Huan Xiang Shi Jie" were open for public testing on September 23 and October 18 respectively, while "Yi Xiang Hui Sheng", "Yi Wan Guang Nian", etc., are expected to launch within the year, and "Zui Qiang Cheng Bao" and "Chong A Yuan Shi Ren" have also obtained approval numbers.

On October 30, shenzhen mindray bio-medical electronics announced that based on its total share capital of 1,212,441,394 shares as of September 30, 2024, it plans to distribute cash dividends of 16.50 RMB (including tax) for every 10 shares to all shareholders, with a total planned cash dividend distribution of 2 billion yuan. The equity registration date for this distribution is November 6, 2024, and the ex-dividend date is November 7, 2024. In a research report released by Du Xiangyang and others at Southwest Securities on November 7, it was noted that shenzhen mindray bio-medical electronics continues to increase its product innovation and research and development efforts, especially in high-end fields. shenzhen mindray bio-medical electronics is accelerating the expansion of the "Ruizhi Lian" ecosystem's application scenarios in hospitals. Based on shenzhen mindray bio-medical electronics' layout and advantages in medical monitors, anesthesia machines, ventilators, infusion pumps, and other products, multiple scenario solutions have been launched including hospital-wide, critical care, perioperative, emergency, cardiac, and general nursing.

In a research report released by Sun Jian and others at zheshang on October 30, it was stated that yunnan baiyao group plans to distribute cash dividends of 12.13 RMB (including tax) for every 10 shares to all shareholders, with a total dividend amount of 2.164 billion yuan, accounting for 50.02% of the company’s net income attributable to shareholders for the first three quarters. Increasing the frequency of dividends and optimizing the rhythm of dividends can enhance investors' sense of gain, boost investor confidence, and continuously improve the inherent value and market value of the company. On November 13, yunnan baiyao group published an announcement of the record of its investor research meeting, stating that the company is promoting the restructuring and adjustment of its emerging business division, with rapid progress in business development in the health supplement division, skincare division, and medical instruments division. During the reporting period, the skincare division launched a new self-developed raw material—Qiu Yao Ge Zhong Lou, which has won two prizes for ICIC raw materials and products, and concurrently launched the "Cai Zhi Ji – Qiu Yao Ge Zhong Lou" series of products on multiple platforms such as Tmall and jd.com, mainly promoting anti-inflammatory, soothing, and redness-repairing effects, effectively applying herbal extractions in the field of skincare.

On October 29, deye shares released an announcement of the profit distribution plan for the first three quarters, proposing to distribute 12.0 yuan for every 10 shares, with a total cash dividend distribution of 0.774 billion yuan. Liu Qiang and others at the pacific securities stated in a research report on November 6 that thanks to years of early deployment in emerging markets such as Africa, Asia, and Latin America, as well as continuous investment in the european market, in 2024, although the company’s market in South Africa has significantly declined year-on-year, it has captured the emerging market demands in Pakistan, Ukraine, Germany, india, the Philippines, Myanmar, and others, further expanding its market coverage. Meanwhile, the sales of power inverters have driven the sales of energy storage battery products, leading to rapid growth in energy storage battery sales. The company’s R&D side has deepened its understanding of market needs, continuously exploring user scenarios and developing products such as balcony mini energy storage power inverters and commercial energy storage PCS-100KW series.

On October 25, China Resources Sanjiu Medical & Pharmaceutical announced that the profit distribution plan for the first three quarters of 2024 is: only distribution, no capital increase; based on the total share capital on the equity registration date when the distribution plan is implemented, a cash dividend of 10 yuan per 10 shares (tax included) will be distributed. As of September 30, 2024, the company's total share capital is 1,284,325,466 shares, which means the total cash dividend to be distributed is 1,284,325,466 yuan (tax included), accounting for 43.39% of the net income attributable to shareholders of the listed company for the first three quarters of 2024. Allianz Ruishi released the profit distribution plan announcement for the third quarter on November 4, proposing a cash dividend of 10.0 yuan per 10 shares, totaling a cash dividend of 67.6489 million yuan.